Impact of ataxia-telangiectasia mutated (ATM) loss on radiobiological and immune response to radium-223 in prostate cancer in vitro models
Clinical and Translational Radiation Oncology · 2026-07 · 59 · 101206
DOI: 10.1016/j.ctro.2026.101206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Radiation Oncology, 2026-07. Verfasst von Victoria L Dunne und 6 weiteren Autor:innen. Beteiligte Einrichtung: Johnston Cancer Research Centre, Queen's University Belfast, Northern Ireland, UK. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Public Health Agency, Prostate Cancer UK, Cancer Research UK.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Johnston Cancer Research Centre, Queen's University Belfast, Northern Ireland, UK.
- Northern Ireland Cancer Centre, Belfast Health & Social Care Trust, Northern Ireland, UK.
Förderung
- Public Health Agency
- Prostate Cancer UK
- Cancer Research UK
- Movember Foundation
Zitieren
APA
Dunne, V. L., Wright, T. C., Toner, A., Wilson, M. L., Savage, K. I., O'Sullivan, J. M., & Prise, K. M. (2026). Impact of ataxia-telangiectasia mutated (ATM) loss on radiobiological and immune response to radium-223 in prostate cancer in vitro models. Clinical and Translational Radiation Oncology, 59, 101206. https://doi.org/10.1016/j.ctro.2026.101206
Vancouver
Dunne VL, Wright TC, Toner A, Wilson ML, Savage KI, O'Sullivan JM, et al. Impact of ataxia-telangiectasia mutated (ATM) loss on radiobiological and immune response to radium-223 in prostate cancer in vitro models. Clinical and Translational Radiation Oncology. 2026;59:101206. doi:10.1016/j.ctro.2026.101206
BibTeX
@article{Dunne2026,
author = {Dunne, Victoria L and Wright, Timothy C and Toner, Aislinn and Wilson, Melissa LaBonte and Savage, Kienan I and O'Sullivan, Joe M and Prise, Kevin M},
title = {Impact of ataxia-telangiectasia mutated (ATM) loss on radiobiological and immune response to radium-223 in prostate cancer in vitro models},
journal = {Clinical and Translational Radiation Oncology},
year = {2026},
volume = {59},
pages = {101206},
doi = {10.1016/j.ctro.2026.101206}
}
EUVIMED